English
简体中文
Total: £ 56.28
Published Date: 2026-01-30 | Pages: 108 | Tables: 116 | Pharma & Healthcare
The global Cannabis Pharmaceuticals market was valued at US$ 1483 million in 2025 and is anticipated to reach US$ 3621 million by 2032, at a CAGR of 13.8% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cannabis Pharmaceuticals competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Cannabis pharmaceuticals refers to the development and sale of pharmaceutical drugs or medicines with compounds of cannabis plants acting as key components. The plant belongs to the Cannabaceae family of flowering plants and produces a highly popular psychoactive drug called marijuana or cannabis. The plant is indigenous to South and Central Asia. It is widely used as a recreational drug. However, in recent times, the pharmaceutical industry has invested heavily in exploring the plant and its components for their medicinal attributes. Two of the most well-researched and popular components are cannabidiol (CBD) and tetrahydrocannabinol (THC) since they are known to exhibit several therapeutic effects. Cannabis pharmaceuticals deal with exploring a combination of cannabinoids and studying their impact on diseases or health conditions under a controlled environment and in the guidance of a licensed supervisor such as a medical practitioner. Medicines produced using cannabis are available in several forms including sprays, capsules, and tablets. The medicines cannot be rolled out in the commercial market without receiving necessary approvals from regulatory bodies.
The North American market for Cannabis Pharmaceuticals is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cannabis Pharmaceuticals is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Cannabis Pharmaceuticals include Cronos Group, Jazz Pharmaceuticals, Elixinol Wellness, Trulieve, Tilray Brands, Inc., Cansortium Inc., Aurora Cannabis, Canopy Growth, Cresco Labs, Organigram, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cannabis Pharmaceuticals market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cannabis Pharmaceuticals. The Cannabis Pharmaceuticals market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cannabis Pharmaceuticals market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cannabis Pharmaceuticals manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Cronos Group
Jazz Pharmaceuticals
Elixinol Wellness
Trulieve
Tilray Brands, Inc.
Cansortium Inc.
Aurora Cannabis
Canopy Growth
Cresco Labs
Organigram
Segment by Type
Sprays
Capsules
Tablets
Others
by Application
Pharmacies
Hospitals
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Cannabis Pharmaceuticals manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Cannabis Pharmaceuticals sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Cannabis Pharmaceuticals Market Overview
1.1 Product Definition
1.2 Cannabis Pharmaceuticals by Type
1.2.1 Global Cannabis Pharmaceuticals Market Value by Type: 2025 vs 2032
1.2.2 Sprays
1.2.3 Capsules
1.2.4 Tablets
1.2.5 Others
1.3 Cannabis Pharmaceuticals by Application
1.3.1 Global Cannabis Pharmaceuticals Market Value by Application: 2025 vs 2032
1.3.2 Pharmacies
1.3.3 Hospitals
1.3.4 Others
1.4 Global Cannabis Pharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Cannabis Pharmaceuticals Revenue 2021–2032
1.4.2 Global Cannabis Pharmaceuticals Sales 2021–2032
1.4.3 Global Cannabis Pharmaceuticals Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Cannabis Pharmaceuticals Market Competition by Manufacturers
2.1 Global Cannabis Pharmaceuticals Sales Market Share by Manufacturers (2021–2026)
2.2 Global Cannabis Pharmaceuticals Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Cannabis Pharmaceuticals Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Cannabis Pharmaceuticals, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Cannabis Pharmaceuticals, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Cannabis Pharmaceuticals, Product Types and Applications
2.7 Global Key Manufacturers of Cannabis Pharmaceuticals, Date of Entry into the Industry
2.8 Global Cannabis Pharmaceuticals Market Competitive Situation and Trends
2.8.1 Global Cannabis Pharmaceuticals Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Cannabis Pharmaceuticals Players Market Share by Revenue
2.8.3 Global Cannabis Pharmaceuticals Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cannabis Pharmaceuticals Market Scenario by Region
3.1 Global Cannabis Pharmaceuticals Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Cannabis Pharmaceuticals Sales by Region: 2021–2032
3.2.1 Global Cannabis Pharmaceuticals Sales by Region: 2021–2026
3.2.2 Global Cannabis Pharmaceuticals Sales by Region: 2027–2032
3.3 Global Cannabis Pharmaceuticals Revenue by Region: 2021–2032
3.3.1 Global Cannabis Pharmaceuticals Revenue by Region: 2021–2026
3.3.2 Global Cannabis Pharmaceuticals Revenue by Region: 2027–2032
3.4 North America Cannabis Pharmaceuticals Market Facts & Figures by Country
3.4.1 North America Cannabis Pharmaceuticals Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Cannabis Pharmaceuticals Sales by Country (2021–2032)
3.4.3 North America Cannabis Pharmaceuticals Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cannabis Pharmaceuticals Market Facts & Figures by Country
3.5.1 Europe Cannabis Pharmaceuticals Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Cannabis Pharmaceuticals Sales by Country (2021–2032)
3.5.3 Europe Cannabis Pharmaceuticals Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cannabis Pharmaceuticals Market Facts & Figures by Region
3.6.1 Asia Pacific Cannabis Pharmaceuticals Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Cannabis Pharmaceuticals Sales by Region (2021–2032)
3.6.3 Asia Pacific Cannabis Pharmaceuticals Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cannabis Pharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America Cannabis Pharmaceuticals Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Cannabis Pharmaceuticals Sales by Country (2021–2032)
3.7.3 Latin America Cannabis Pharmaceuticals Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cannabis Pharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa Cannabis Pharmaceuticals Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Cannabis Pharmaceuticals Sales by Country (2021–2032)
3.8.3 Middle East and Africa Cannabis Pharmaceuticals Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cannabis Pharmaceuticals Sales by Type (2021–2032)
4.1.1 Global Cannabis Pharmaceuticals Sales by Type (2021–2026)
4.1.2 Global Cannabis Pharmaceuticals Sales by Type (2027–2032)
4.1.3 Global Cannabis Pharmaceuticals Sales Market Share by Type (2021–2032)
4.2 Global Cannabis Pharmaceuticals Revenue by Type (2021–2032)
4.2.1 Global Cannabis Pharmaceuticals Revenue by Type (2021–2026)
4.2.2 Global Cannabis Pharmaceuticals Revenue by Type (2027–2032)
4.2.3 Global Cannabis Pharmaceuticals Revenue Market Share by Type (2021–2032)
4.3 Global Cannabis Pharmaceuticals Price by Type (2021–2032)
5 Segment by Application
5.1 Global Cannabis Pharmaceuticals Sales by Application (2021–2032)
5.1.1 Global Cannabis Pharmaceuticals Sales by Application (2021–2026)
5.1.2 Global Cannabis Pharmaceuticals Sales by Application (2027–2032)
5.1.3 Global Cannabis Pharmaceuticals Sales Market Share by Application (2021–2032)
5.2 Global Cannabis Pharmaceuticals Revenue by Application (2021–2032)
5.2.1 Global Cannabis Pharmaceuticals Revenue by Application (2021–2026)
5.2.2 Global Cannabis Pharmaceuticals Revenue by Application (2027–2032)
5.2.3 Global Cannabis Pharmaceuticals Revenue Market Share by Application (2021–2032)
5.3 Global Cannabis Pharmaceuticals Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Cronos Group
6.1.1 Cronos Group Company Information
6.1.2 Cronos Group Description and Business Overview
6.1.3 Cronos Group Cannabis Pharmaceuticals Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Cronos Group Cannabis Pharmaceuticals Product Portfolio
6.1.5 Cronos Group Recent Developments/Updates
6.2 Jazz Pharmaceuticals
6.2.1 Jazz Pharmaceuticals Company Information
6.2.2 Jazz Pharmaceuticals Description and Business Overview
6.2.3 Jazz Pharmaceuticals Cannabis Pharmaceuticals Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Portfolio
6.2.5 Jazz Pharmaceuticals Recent Developments/Updates
6.3 Elixinol Wellness
6.3.1 Elixinol Wellness Company Information
6.3.2 Elixinol Wellness Description and Business Overview
6.3.3 Elixinol Wellness Cannabis Pharmaceuticals Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Elixinol Wellness Cannabis Pharmaceuticals Product Portfolio
6.3.5 Elixinol Wellness Recent Developments/Updates
6.4 Trulieve
6.4.1 Trulieve Company Information
6.4.2 Trulieve Description and Business Overview
6.4.3 Trulieve Cannabis Pharmaceuticals Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Trulieve Cannabis Pharmaceuticals Product Portfolio
6.4.5 Trulieve Recent Developments/Updates
6.5 Tilray Brands, Inc.
6.5.1 Tilray Brands, Inc. Company Information
6.5.2 Tilray Brands, Inc. Description and Business Overview
6.5.3 Tilray Brands, Inc. Cannabis Pharmaceuticals Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Tilray Brands, Inc. Cannabis Pharmaceuticals Product Portfolio
6.5.5 Tilray Brands, Inc. Recent Developments/Updates
6.6 Cansortium Inc.
6.6.1 Cansortium Inc. Company Information
6.6.2 Cansortium Inc. Description and Business Overview
6.6.3 Cansortium Inc. Cannabis Pharmaceuticals Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Cansortium Inc. Cannabis Pharmaceuticals Product Portfolio
6.6.5 Cansortium Inc. Recent Developments/Updates
6.7 Aurora Cannabis
6.7.1 Aurora Cannabis Company Information
6.7.2 Aurora Cannabis Description and Business Overview
6.7.3 Aurora Cannabis Cannabis Pharmaceuticals Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Aurora Cannabis Cannabis Pharmaceuticals Product Portfolio
6.7.5 Aurora Cannabis Recent Developments/Updates
6.8 Canopy Growth
6.8.1 Canopy Growth Company Information
6.8.2 Canopy Growth Description and Business Overview
6.8.3 Canopy Growth Cannabis Pharmaceuticals Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Canopy Growth Cannabis Pharmaceuticals Product Portfolio
6.8.5 Canopy Growth Recent Developments/Updates
6.9 Cresco Labs
6.9.1 Cresco Labs Company Information
6.9.2 Cresco Labs Description and Business Overview
6.9.3 Cresco Labs Cannabis Pharmaceuticals Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cresco Labs Cannabis Pharmaceuticals Product Portfolio
6.9.5 Cresco Labs Recent Developments/Updates
6.10 Organigram
6.10.1 Organigram Company Information
6.10.2 Organigram Description and Business Overview
6.10.3 Organigram Cannabis Pharmaceuticals Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Organigram Cannabis Pharmaceuticals Product Portfolio
6.10.5 Organigram Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cannabis Pharmaceuticals Industry Chain Analysis
7.2 Cannabis Pharmaceuticals Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cannabis Pharmaceuticals Production Mode & Process Analysis
7.4 Cannabis Pharmaceuticals Sales and Marketing
7.4.1 Cannabis Pharmaceuticals Sales Channels
7.4.2 Cannabis Pharmaceuticals Distributors
7.5 Cannabis Pharmaceuticals Customer Analysis
8 Cannabis Pharmaceuticals Market Dynamics
8.1 Cannabis Pharmaceuticals Industry Trends
8.2 Cannabis Pharmaceuticals Market Drivers
8.3 Cannabis Pharmaceuticals Market Challenges
8.4 Cannabis Pharmaceuticals Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Cannabis Pharmaceuticals Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Cannabis Pharmaceuticals Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Cannabis Pharmaceuticals Market Competitive Situation by Manufacturers in 2025
Table 4. Global Cannabis Pharmaceuticals Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global Cannabis Pharmaceuticals Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Cannabis Pharmaceuticals Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Cannabis Pharmaceuticals Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Cannabis Pharmaceuticals Average Price (US$/g) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Cannabis Pharmaceuticals, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Cannabis Pharmaceuticals, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Cannabis Pharmaceuticals, Product Types and Applications
Table 12. Global Key Manufacturers of Cannabis Pharmaceuticals, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cannabis Pharmaceuticals Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cannabis Pharmaceuticals Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cannabis Pharmaceuticals Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Cannabis Pharmaceuticals Sales by Region (kg), 2021–2026
Table 18. Global Cannabis Pharmaceuticals Sales Market Share by Region (2021–2026)
Table 19. Global Cannabis Pharmaceuticals Sales by Region (kg), 2027–2032
Table 20. Global Cannabis Pharmaceuticals Sales Market Share by Region (2027–2032)
Table 21. Global Cannabis Pharmaceuticals Revenue by Region (US$ Million), 2021–2026
Table 22. Global Cannabis Pharmaceuticals Revenue Market Share by Region (2021–2026)
Table 23. Global Cannabis Pharmaceuticals Revenue by Region (US$ Million), 2027–2032
Table 24. Global Cannabis Pharmaceuticals Revenue Market Share by Region (2027–2032)
Table 25. North America Cannabis Pharmaceuticals Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Cannabis Pharmaceuticals Sales by Country (kg), 2021–2026
Table 27. North America Cannabis Pharmaceuticals Sales by Country (kg), 2027–2032
Table 28. North America Cannabis Pharmaceuticals Revenue by Country (US$ Million), 2021–2026
Table 29. North America Cannabis Pharmaceuticals Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Cannabis Pharmaceuticals Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Cannabis Pharmaceuticals Sales by Country (kg), 2021–2026
Table 32. Europe Cannabis Pharmaceuticals Sales by Country (kg), 2027–2032
Table 33. Europe Cannabis Pharmaceuticals Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Cannabis Pharmaceuticals Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Cannabis Pharmaceuticals Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Cannabis Pharmaceuticals Sales by Region (kg), 2021–2026
Table 37. Asia Pacific Cannabis Pharmaceuticals Sales by Region (kg), 2027–2032
Table 38. Asia Pacific Cannabis Pharmaceuticals Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Cannabis Pharmaceuticals Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Cannabis Pharmaceuticals Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Cannabis Pharmaceuticals Sales by Country (kg), 2021–2026
Table 42. Latin America Cannabis Pharmaceuticals Sales by Country (kg), 2027–2032
Table 43. Latin America Cannabis Pharmaceuticals Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Cannabis Pharmaceuticals Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Cannabis Pharmaceuticals Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Cannabis Pharmaceuticals Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa Cannabis Pharmaceuticals Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa Cannabis Pharmaceuticals Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Cannabis Pharmaceuticals Revenue by Country (US$ Million), 2027–2032
Table 50. Global Cannabis Pharmaceuticals Sales (kg) by Type (2021–2026)
Table 51. Global Cannabis Pharmaceuticals Sales (kg) by Type (2027–2032)
Table 52. Global Cannabis Pharmaceuticals Sales Market Share by Type (2021–2026)
Table 53. Global Cannabis Pharmaceuticals Sales Market Share by Type (2027–2032)
Table 54. Global Cannabis Pharmaceuticals Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Cannabis Pharmaceuticals Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Cannabis Pharmaceuticals Revenue Market Share by Type (2021–2026)
Table 57. Global Cannabis Pharmaceuticals Revenue Market Share by Type (2027–2032)
Table 58. Global Cannabis Pharmaceuticals Price (US$/g) by Type (2021–2026)
Table 59. Global Cannabis Pharmaceuticals Price (US$/g) by Type (2027–2032)
Table 60. Global Cannabis Pharmaceuticals Sales (kg) by Application (2021–2026)
Table 61. Global Cannabis Pharmaceuticals Sales (kg) by Application (2027–2032)
Table 62. Global Cannabis Pharmaceuticals Sales Market Share by Application (2021–2026)
Table 63. Global Cannabis Pharmaceuticals Sales Market Share by Application (2027–2032)
Table 64. Global Cannabis Pharmaceuticals Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Cannabis Pharmaceuticals Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Cannabis Pharmaceuticals Revenue Market Share by Application (2021–2026)
Table 67. Global Cannabis Pharmaceuticals Revenue Market Share by Application (2027–2032)
Table 68. Global Cannabis Pharmaceuticals Price (US$/g) by Application (2021–2026)
Table 69. Global Cannabis Pharmaceuticals Price (US$/g) by Application (2027–2032)
Table 70. Cronos Group Company Information
Table 71. Cronos Group Description and Business Overview
Table 72. Cronos Group Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 73. Cronos Group Cannabis Pharmaceuticals Product
Table 74. Cronos Group Recent Developments/Updates
Table 75. Jazz Pharmaceuticals Company Information
Table 76. Jazz Pharmaceuticals Description and Business Overview
Table 77. Jazz Pharmaceuticals Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 78. Jazz Pharmaceuticals Cannabis Pharmaceuticals Product
Table 79. Jazz Pharmaceuticals Recent Developments/Updates
Table 80. Elixinol Wellness Company Information
Table 81. Elixinol Wellness Description and Business Overview
Table 82. Elixinol Wellness Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 83. Elixinol Wellness Cannabis Pharmaceuticals Product
Table 84. Elixinol Wellness Recent Developments/Updates
Table 85. Trulieve Company Information
Table 86. Trulieve Description and Business Overview
Table 87. Trulieve Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 88. Trulieve Cannabis Pharmaceuticals Product
Table 89. Trulieve Recent Developments/Updates
Table 90. Tilray Brands, Inc. Company Information
Table 91. Tilray Brands, Inc. Description and Business Overview
Table 92. Tilray Brands, Inc. Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 93. Tilray Brands, Inc. Cannabis Pharmaceuticals Product
Table 94. Tilray Brands, Inc. Recent Developments/Updates
Table 95. Cansortium Inc. Company Information
Table 96. Cansortium Inc. Description and Business Overview
Table 97. Cansortium Inc. Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 98. Cansortium Inc. Cannabis Pharmaceuticals Product
Table 99. Cansortium Inc. Recent Developments/Updates
Table 100. Aurora Cannabis Company Information
Table 101. Aurora Cannabis Description and Business Overview
Table 102. Aurora Cannabis Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 103. Aurora Cannabis Cannabis Pharmaceuticals Product
Table 104. Aurora Cannabis Recent Developments/Updates
Table 105. Canopy Growth Company Information
Table 106. Canopy Growth Description and Business Overview
Table 107. Canopy Growth Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 108. Canopy Growth Cannabis Pharmaceuticals Product
Table 109. Canopy Growth Recent Developments/Updates
Table 110. Cresco Labs Company Information
Table 111. Cresco Labs Description and Business Overview
Table 112. Cresco Labs Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 113. Cresco Labs Cannabis Pharmaceuticals Product
Table 114. Cresco Labs Recent Developments/Updates
Table 115. Organigram Company Information
Table 116. Organigram Description and Business Overview
Table 117. Organigram Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 118. Organigram Cannabis Pharmaceuticals Product
Table 119. Organigram Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Cannabis Pharmaceuticals Distributors List
Table 123. Cannabis Pharmaceuticals Customers List
Table 124. Cannabis Pharmaceuticals Market Trends
Table 125. Cannabis Pharmaceuticals Market Drivers
Table 126. Cannabis Pharmaceuticals Market Challenges
Table 127. Cannabis Pharmaceuticals Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cannabis Pharmaceuticals
Figure 2. Global Cannabis Pharmaceuticals Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Cannabis Pharmaceuticals Market Share by Type: 2025 & 2032
Figure 4. Sprays Product Picture
Figure 5. Capsules Product Picture
Figure 6. Tablets Product Picture
Figure 7. Others Product Picture
Figure 8. Global Cannabis Pharmaceuticals Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Cannabis Pharmaceuticals Market Share by Application: 2025 & 2032
Figure 10. Pharmacies
Figure 11. Hospitals
Figure 12. Others
Figure 13. Global Cannabis Pharmaceuticals Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Cannabis Pharmaceuticals Market Size (US$ Million), 2021–2032
Figure 15. Global Cannabis Pharmaceuticals Sales (kg), 2021–2032
Figure 16. Global Cannabis Pharmaceuticals Average Price (US$/g), 2021–2032
Figure 17. Cannabis Pharmaceuticals Report Years Considered
Figure 18. Cannabis Pharmaceuticals Sales Share by Manufacturers in 2025
Figure 19. Global Cannabis Pharmaceuticals Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Cannabis Pharmaceuticals Players: Market Share by Revenue in Cannabis Pharmaceuticals in 2025
Figure 21. Cannabis Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Cannabis Pharmaceuticals Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Cannabis Pharmaceuticals Sales Market Share by Country (2021–2032)
Figure 24. North America Cannabis Pharmaceuticals Revenue Market Share by Country (2021–2032)
Figure 25. United States Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Cannabis Pharmaceuticals Sales Market Share by Country (2021–2032)
Figure 28. Europe Cannabis Pharmaceuticals Revenue Market Share by Country (2021–2032)
Figure 29. Germany Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Cannabis Pharmaceuticals Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Cannabis Pharmaceuticals Revenue Market Share by Region (2021–2032)
Figure 36. China Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Cannabis Pharmaceuticals Sales Market Share by Country (2021–2032)
Figure 44. Latin America Cannabis Pharmaceuticals Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Cannabis Pharmaceuticals Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Cannabis Pharmaceuticals Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Cannabis Pharmaceuticals Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Cannabis Pharmaceuticals by Type (2021–2032)
Figure 55. Global Revenue Market Share of Cannabis Pharmaceuticals by Type (2021–2032)
Figure 56. Global Cannabis Pharmaceuticals Price (US$/g) by Type (2021–2032)
Figure 57. Global Sales Market Share of Cannabis Pharmaceuticals by Application (2021–2032)
Figure 58. Global Revenue Market Share of Cannabis Pharmaceuticals by Application (2021–2032)
Figure 59. Global Cannabis Pharmaceuticals Price (US$/g) by Application (2021–2032)
Figure 60. Cannabis Pharmaceuticals Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
